NeuroPace Inc. (NPCE)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
NPCE's IGE expansion faces a regulatory delay, shifting focus to rising RNS adoption as the company works through the FDA review process.
Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
NPCE's stronger RNS adoption, narrowing losses and AI expansion support growth, but premium valuation, liquidity and regulatory risks warrant patience.
NPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity?
NeuroPace's stronger RNS growth, raised 2026 guidance and AI expansion face a less certain IGE regulatory path after the FDA setback.
NeuroPace Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 14 | $184 | $194.6 | $10.6 | 5.76% |
| LJB Laura J. Bornheimer GWN SECURITIES Inc. | 25,470 | $342,674.11 | $328,308.3 | -$14,365.81 | -4.19% |
 Anthony Scaramucci SkyBridge Capital II LLC | 692,000 | $8.22M | $10.22M | $2M | 24.4% |
 Joseph Castro Nuveen LLC | 99,498 | $1.44M | $1.48M | $41,793.56 | 2.9% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 8 | $105.2 | $103.12 | -$2.08 | -1.98% |
NeuroPace Inc. (NPCE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has NeuroPace Inc. ever had a stock split?
NeuroPace Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Joel D. Becker CEO | NASDAQ (NMS) Exchange | 641288105 CUSIP |
| US Country | 220 Employees | - Last Dividend | - Last Split | 22 Apr 2021 IPO Date |
Overview
NeuroPace, Inc. is a medical device company based in the United States, specifically headquartered in Mountain View, California. Founded in 1997, the company focuses on developing innovative solutions for patients with medically refractory focal epilepsy. Its flagship product, the RNS System, represents a significant advancement in brain-responsive neuromodulation technology. This system offers personalized, real-time treatment by targeting the seizure source directly within the brain. Beyond its primary mission to improve the quality of life for individuals suffering from focal epilepsy, NeuroPace, Inc. takes pride in its contributions to the broader medical and scientific communities through continuous brain activity data collection. This data not only aids in the personal monitoring of patients by clinicians but also supports remote patient management, enhancing care delivery and patient outcomes.
Products and Services
The RNS System is NeuroPace, Inc.'s premier solution, comprising several components and services designed to support the needs of both patients and healthcare providers:
- RNS Neurostimulator: At the core of the RNS System, the neurostimulator is a brain-responsive device that analyzes brain activity to detect abnormal patterns and delivers subtle electrical pulses to normalize brain activity before seizures can occur.
- Cortical Strip and Depth Leads: These leads are connected to the RNS Neurostimulator and placed at strategic locations within the brain to record electrical activity and deliver stimulation directly to the seizure source.
- Patient Remote Monitor: Enables patients to transmit data collected by the RNS System to their healthcare providers, facilitating both in-person and remote monitoring of their condition. This tool is crucial for the ongoing assessment of treatment efficacy and the adjustment of therapy parameters as necessary.
- Implantable and Non-Implantable Accessories: To support the functionality of the RNS System, NeuroPace, Inc. offers a range of additional accessories necessary for the initial implant procedure and for ongoing maintenance or replacement procedures.
These products and services are delivered to hospital facilities across the United States, emphasizing the company's commitment to providing comprehensive solutions for the treatment and management of medically refractory focal epilepsy. Through its innovative offerings, NeuroPace, Inc. seeks to redefine the standard of care for epilepsy patients, offering them hope for a better quality of life.
